BioNxt Solutions Inc.
BNXT
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.53% | 8.87% | 29.26% | 32.15% | 48.92% |
| Total Depreciation and Amortization | -74.39% | -66.54% | -63.59% | -53.79% | -43.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.53% | 66.92% | 9.79% | -26.90% | -79.46% |
| Change in Net Operating Assets | -175.16% | -63.75% | -93.20% | 65.47% | 2,844.10% |
| Cash from Operations | -55.33% | 20.35% | 29.32% | 42.24% | 38.96% |
| Capital Expenditure | -- | -- | -- | -- | 28.90% |
| Sale of Property, Plant, and Equipment | -64.07% | -77.48% | -55.40% | -81.50% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -71.04% | -70.54% | 33.56% | -43.70% | 330.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -29,376.34% | -14,717.84% | -333.61% | -317.49% | 99.73% |
| Issuance of Common Stock | -22.41% | -82.88% | -61.57% | -69.10% | -47.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -193.15% | -48.18% | -715.78% | 36.94% | 43.99% |
| Cash from Financing | 118.06% | -24.21% | 25.04% | -50.89% | -36.17% |
| Foreign Exchange rate Adjustments | -60.71% | 66.67% | 254.55% | 140.00% | 33.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 171.61% | -719.93% | 112.67% | -250.40% | 67.37% |